Incorporating concerns for equal lifetime health in evaluations of public health programs

Social Science and Medicine

Volumn 72, Issue 10, 2011, Pages 1711-1716

  Robberstad, Bjarne ^a   Norheim, Ole F ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Achievement index; Cost effectiveness; Economic evaluation; Equity; Gini index; Hypertension treatment; Pneumococcal vaccine; Tanzania

Indexed keywords

HYDROCHLOROTHIAZIDE; PNEUMOCOCCUS VACCINE;

COMPUTER SIMULATION; DISEASE TREATMENT; EQUITY; HEALTH CARE; HEALTH SERVICES; HEALTH STATUS; LOW INCOME POPULATION; NUMERICAL MODEL; PLANNING METHOD; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; VACCINATION;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DISTRIBUTION; HEALTH CARE NEED; HEALTH PROGRAM; HUMAN; HYPERTENSION; LIFE EXPECTANCY; LOWEST INCOME GROUP; MASS IMMUNIZATION; QUALITY OF LIFE; TANZANIA; TREATMENT OUTCOME;

AGED; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; HEALTH CARE RATIONING; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERTENSION; MIDDLE AGED; MODELS, STATISTICAL; PNEUMOCOCCAL VACCINES; PROGRAM EVALUATION; PUBLIC HEALTH; STATISTICS AS TOPIC; TANZANIA;

TANZANIA;

EID: 79955952339     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2011.03.032     Document Type: Article

References (39)

1. AMMP (2004). AMMP Final Report - The Policy Implications of Tanzanias Mortality Burden: a 10 year community-based perspective (Final Report). Dar es Salaam: Adult Mortality and Morbidity Project - Ministry of Health.
2. Anand S. The concern for equity in health. Journal of Epidemiology and Community Health 2002, 56:485-487.
3. Bernatoniene J., Finn A. Advances in pneumococcal vaccines: advantages for infants and children. Drugs 2005, 65(2):229-255.
4. Bleichrodt H., Doctor J., Stolk E. A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. Journal of Health Economics 2005, 24(4):655-678.
5. Bleichrodt H., van Doorslaer E. A welfare economics foundation for health inequality measurement. Journal of Health Economics 2006, 25(5):945-957.
6. Bovet P., Ross A.G., Gervasoni J.P., Mkamba M., Mtasiwa D.M., Lengeler C., et al. Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socioeconomic status. International Journal of Epidemiology 2002, 31(1):240-247.
7. Brock D., Wikler D. Ethical issues in resource allocation, research, and New Product Development. Disease Control priorities in developing countries 2006, 259-270. Oxford University Press and The World Bank, New York. 2nd ed. D.T. Jamison, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson, D.B. Evans, P. Jha, A. Mills, P. Musgrove (Eds.).
8. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365(9465):1139-1146.
9. Daniels N. The ideal advocate and limited resources. Theoretical Medicine 1987, 8(1):69-80.
10. Dolan P. The measurement of individual utility and social welfare. Journal of Health Economics 1998, 17(1):39-52.
11. Dolan P., Shaw R., Tsuchiya A., Williams A. QALY maximisation and people's preferences: a methodological review of the literature. Health Econ 2005, 14(2):197-208.
12. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Methods for the economic evaluation of health care Programmes 2005, Oxford University Press, Oxford New York. 3rd ed.
13. Hutubessy R., Chisholm D., Tan-Torres Edejer T., WHO-CHOICE o.b.o Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Effectiveness and Resource Allocation 2003, 1(8):1-29.
14. Jamison D.T., Breman J.G., Measham A.R., Alleyne G., Claeson M., Evans D.B., et al. Disease Control priorities in developing countries 2006, The World Bank and Oxford University Press, New York. 2nd ed.
15. Lopez, A. D., Ahmad, O. B., Guillot, M., Inoue, M., Ferguson, B. D., & Salomon, J. A. (2001). Life Tables for 191 countries for 2000: Data, Methods, Results (GPE Discussion Paper No. 40). (Health Systems Performance Assessment Peer Review Technical Documentation).
16. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367(9524):1747-1757.
17. Maestad O., Norheim O.F. Eliciting people's preferences for the distribution of health: a procedure for a more precise estimation of distributional weights. Journal of Health Economics 2009, 28(3):570-577.
18. Masanja H., de Savigny D., Smithson P., Schellenberg J., John T., Mbuya C., et al. Child survival gains in Tanzania: analysis of data from demographic and health surveys. Lancet 2008, 371(9620):1276-1283.
19. Murray C., Evans D.B., Acharya A., Baltussen R.M.P.M. Development of WHO Guidelines on Generalized cost-effectiveness analysis. Health Economics 2000, 9:235-251.
20. Nord E. An alternative to QALYs: the saved young life equivalent (SAVE). British Medical Journal 1992, 305(6858):875-877.
21. Nord E., Pinto J.L., Richardson J., Menzel P., Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Economics 1999, 8(1):25-39.
22. Norheim O.F. Implementing the Marmot Commission's Recommendations: social Justice requires a solution to the equity-efficiency trade-Off. Public Health Ethics 2009, 2(1):53-58.
23. Norheim O.F. Gini impact analysis: measuring pure health inequity before and after interventions. Public Health Ethics 2010, 3(3):10.
24. Robberstad B., Hemed Y., Norheim O.F. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation 2007, 5:3.
25. Sassi F., Archard L., Le Grand J. Equity and the economic evaluation of healthcare. Health Technology Assessment 2001, 5(3).
26. Sen A. Why health equity?. Health Economics 2002, 11:659-666.
27. Setel P., Hemed Y., Whiting D., Masanja H., Lewanga M., Mswia R., et al. The worst of two worlds: adult mortality in the United Republic of Tanzania. Insights Health 2001.
28. Sinha A., Levine O., Knoll M.D., Muhib F., Lieu T.A. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet 2007, 369(9559):389-396.
29. Stolk E.A., Pickee S.J., Ament A.H.J.A., Busschbach J.J.V. Equity in health care prioritisation: an empirical inquiry into social value. Health Policy 2005, 74:343-355.
30. Temkin L. Inequality 1993, Oxford University Press, New York.
31. Tsuchiya A. Age-related preferences and age weighting health benefits. Social Science & Medicine 1999, 48(2):267-276.
32. Tsuchiya A. QALYs and ageism: philosophical theories and age weighting. Health Economics 2000, 9(1):57-68.
33. Ubel P.A., Nord E., Gold M., Menzel P., Prades J.L., Richardson J. Improving value measurement in cost-effectiveness analysis. Medical Care 2000, 38(9):892-901.
34. Wagstaff A. Inequality aversion, health inequalities and health achievement. Journal of Health Economics 2002, 21(4):627-641.
35. Wagstaff A., van Doorslaer E. Overall versus socioeconomic health inequality: a measurement framework and two empirical illustrations. Health Economics 2004, 13(3):297-301.
36. Walker R.W., McLarty D.G., Kitange H.M., Whiting D., Masuki G., Mtasiwa D.M., et al. Stroke mortality in urban and rural Tanzania. Adult Morbidity and mortality Project. Lancet 2000, 355(9216):1684-1687.
37. Williams A. Intergenerational equity: an exploration of the 'fair innings' argument. Health Economics 1997, 6(2):117-132.
38. Williams A. Inequalities in health and intergenerational equity. Ethical Theory & Moral Practice 1999, 2(1):47-55.
39. Zar H.J., Madhi S.A. Pneumococcal conjugate vaccine-a health priority. South African Journal of Sports Medicine 2008, 98(6):463-467.